{"id":"https://openalex.org/W3127077340","doi":"https://doi.org/10.1007/s12325-021-01623-y","title":"A Japanese Study Assessing Glycemic Control with Use of IDegAsp Co-formulation in Patients with Type 2 Diabetes in Clinical Practice: The JAGUAR Study","display_name":"A Japanese Study Assessing Glycemic Control with Use of IDegAsp Co-formulation in Patients with Type 2 Diabetes in Clinical Practice: The JAGUAR Study","publication_year":2021,"publication_date":"2021-02-09","ids":{"openalex":"https://openalex.org/W3127077340","doi":"https://doi.org/10.1007/s12325-021-01623-y","mag":"3127077340","pmid":"https://pubmed.ncbi.nlm.nih.gov/33560496","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7932946"},"language":"en","primary_location":{"id":"doi:10.1007/s12325-021-01623-y","doi":"https://doi.org/10.1007/s12325-021-01623-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-021-01623-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-021-01623-y.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s12325-021-01623-y.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101474154","display_name":"Shizuka Kaneko","orcid":"https://orcid.org/0000-0001-6741-218X","observed_orcids":["https://orcid.org/0000-0001-6741-218X"]},"institutions":[{"id":"https://openalex.org/I4210127280","display_name":"Takatsuki Red Cross Hospital","ror":"https://ror.org/02wpa5731","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4210127280"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shizuka Kaneko","raw_affiliation_strings":["Division of Diabetes/Endocrinology/Lifestyle-Related Disease, Takatsuki Red Cross Hospital, Takatsuki, Japan. ayamoesk3218@takatsuki.jrc.or.jp","Division of Diabetes/Endocrinology/Lifestyle-Related Disease, Takatsuki Red Cross Hospital, Takatsuki, Japan"],"raw_orcid":"https://orcid.org/0000-0001-6741-218X","affiliations":[{"raw_affiliation_string":"Division of Diabetes/Endocrinology/Lifestyle-Related Disease, Takatsuki Red Cross Hospital, Takatsuki, Japan. ayamoesk3218@takatsuki.jrc.or.jp","institution_ids":["https://openalex.org/I4210127280"]},{"raw_affiliation_string":"Division of Diabetes/Endocrinology/Lifestyle-Related Disease, Takatsuki Red Cross Hospital, Takatsuki, Japan","institution_ids":["https://openalex.org/I4210127280"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019286521","display_name":"Jo\u00e3o Diogo da Rocha Fernandes","orcid":"https://orcid.org/0000-0002-0036-0749","observed_orcids":["https://orcid.org/0000-0002-0036-0749"]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Jo\u00e3o D. da Rocha Fernandes","raw_affiliation_strings":["Novo Nordisk A/S, Vandt\u00e5rnsvej, S\u00f8borg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Vandt\u00e5rnsvej, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023015579","display_name":"Yuiko Yamamoto","orcid":"https://orcid.org/0000-0003-2673-6238","observed_orcids":["https://orcid.org/0000-0003-2673-6238"]},"institutions":[{"id":"https://openalex.org/I4405265707","display_name":"Novo Nordisk Pharma Ltd. (Japan)","ror":"https://ror.org/05gzvb546","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405265707"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuiko Yamamoto","raw_affiliation_strings":["Novo Nordisk Pharma Ltd, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Pharma Ltd, Tokyo, Japan","institution_ids":["https://openalex.org/I4405265707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020446741","display_name":"J Langer","orcid":"https://orcid.org/0000-0002-0095-1936","observed_orcids":["https://orcid.org/0000-0002-0095-1936"]},"institutions":[{"id":"https://openalex.org/I4405265707","display_name":"Novo Nordisk Pharma Ltd. (Japan)","ror":"https://ror.org/05gzvb546","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405265707"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jakob Langer","raw_affiliation_strings":["Novo Nordisk Pharma Ltd, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Pharma Ltd, Tokyo, Japan","institution_ids":["https://openalex.org/I4405265707"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086346942","display_name":"Mads D. Faurby","orcid":"https://orcid.org/0000-0001-6464-9958","observed_orcids":["https://orcid.org/0000-0001-6464-9958"]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Mads Faurby","raw_affiliation_strings":["Novo Nordisk A/S, Vandt\u00e5rnsvej, S\u00f8borg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Vandt\u00e5rnsvej, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5101474154"],"corresponding_institution_ids":["https://openalex.org/I4210127280"],"apc_list":{"value":3860,"currency":"USD","value_usd":3860},"apc_paid":{"value":3860,"currency":"USD","value_usd":3860},"fwci":1.3734,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":{"value":0.78916545,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"38","issue":"3","first_page":"1638","last_page":"1649"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7451000213623047,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7451000213623047,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.24629999697208405,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9279999732971191},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9010000228881836},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9240000247955322},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9459999799728394},{"id":"https://openalex.org/keywords/insulin-switching","display_name":"insulin switching","score":0.7409999966621399},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.6309999823570251},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.7770000100135803}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9279065132141113},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.7941845655441284},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.7811112403869629},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.6948642730712891},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6418315172195435},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5875943899154663},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5363413691520691},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.4711167812347412},{"id":"https://openalex.org/C2779908123","wikidata":"https://www.wikidata.org/wiki/Q2754775","display_name":"Insulin aspart","level":4,"score":0.4494556486606598},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.39180243015289307},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.30256330966949463}],"mesh":[{"descriptor_ui":"D000085002","descriptor_name":"Glycemic Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046009","descriptor_name":"Panthera","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D061267","descriptor_name":"Insulin Aspart","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s12325-021-01623-y","doi":"https://doi.org/10.1007/s12325-021-01623-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-021-01623-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-021-01623-y.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},{"id":"pmid:33560496","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33560496","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7932946","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7932946/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Adv Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1007/s12325-021-01623-y","doi":"https://doi.org/10.1007/s12325-021-01623-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-021-01623-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-021-01623-y.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3127077340.pdf","grobid_xml":"https://content.openalex.org/works/W3127077340.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W172609984","https://openalex.org/W1978130556","https://openalex.org/W2002856863","https://openalex.org/W2031178950","https://openalex.org/W2035760642","https://openalex.org/W2113386595","https://openalex.org/W2155607555","https://openalex.org/W2166393441","https://openalex.org/W2177119636","https://openalex.org/W2183221358","https://openalex.org/W2281207045","https://openalex.org/W2313662993","https://openalex.org/W2319839537","https://openalex.org/W2337646370","https://openalex.org/W2339680807","https://openalex.org/W2767832909","https://openalex.org/W2793995825","https://openalex.org/W2794676804","https://openalex.org/W2885838436","https://openalex.org/W2886059424","https://openalex.org/W2898518424","https://openalex.org/W2901892849","https://openalex.org/W2901955691","https://openalex.org/W2928197747","https://openalex.org/W4237288256","https://openalex.org/W6749756432"],"related_works":["https://openalex.org/W4392194010","https://openalex.org/W3186705015","https://openalex.org/W4405617101","https://openalex.org/W3041963465","https://openalex.org/W4283458401","https://openalex.org/W2809150485","https://openalex.org/W4399687831","https://openalex.org/W3211825907","https://openalex.org/W4308314784","https://openalex.org/W1978130556"],"abstract_inverted_index":{"The":[0,93],"aim":[1],"of":[2,13,95,110,178,218,253],"this":[3],"study":[4],"was":[5,84,113,146,237],"to":[6,144,172,234],"evaluate":[7],"the":[8,53,64,69],"glycemic":[9,242],"control":[10,243],"and":[11,135,210,216,244],"safety":[12],"insulin":[14,49,233],"degludec/insulin":[15],"aspart":[16],"(IDegAsp)":[17],"co-formulation":[18,236],"in":[19,27,75,247,255],"Japanese":[20,54,256],"patients":[21,34,96,126,179,205,257],"with":[22,44,48,148,239,258],"type":[23],"2":[24],"diabetes":[25],"(T2D)":[26],"a":[28,87,174,245],"real-world":[29],"clinical":[30],"setting,":[31],"including":[32,260],"elderly":[33],"(aged":[35],">":[36,132,212,263],"75":[37,133,208,213,264],"years).":[38],"Patients":[39],"(\u2265":[40],"18":[41],"years)":[42],"diagnosed":[43],"T2D,":[45,259],"previously":[46],"treated":[47],"were":[50,61,127,130,202],"included":[51],"from":[52,232],"Medical":[55],"Data":[56],"Vision":[57],"database.":[58],"Baseline":[59],"data":[60],"taken":[62],"at":[63,81,115,154,187,228],"index":[65],"date,":[66],"defined":[67],"as":[68],"first":[70],"IDegAsp":[71,145,235],"prescription":[72],"claim.":[73],"Change":[74],"glycated":[76],"hemoglobin":[77],"(HbA":[78],"1c":[79,100,140,152,182,223],")":[80],"12":[82,116,155,188,229,251],"months":[83,117,156,252],"estimated":[85],"using":[86],"mixed":[88],"model":[89],"repeated":[90],"measures":[91],"analysis.":[92],"proportion":[94,177],"achieving":[97],"target":[98],"HbA":[99,139,151,181,222],"<":[101,166,183,199,224],"8.0%":[102,184,225],"without":[103,185,226],"experiencing":[104],"hypoglycemia":[105,186,227,248],"(identified":[106],"by":[107],"International":[108],"Classification":[109],"Disease":[111],"codes)":[112],"calculated":[114],"(365":[118],"\u00b1":[119],"90":[120],"days)":[121],"after":[122],"baseline.":[123,169],"Overall,":[124],"10,798":[125],"included,":[128],"3940":[129],"aged":[131,206,211,262],"years,":[134],"913":[136],"had":[137],"baseline":[138],"values":[141,153],"available.":[142],"Switching":[143,231],"associated":[147,238],"significantly":[149,175,240],"improved":[150,241],"(\u2212":[157],"1.23%":[158],"[\u2212":[159],"1.43,":[160],"\u2212":[161],"1.02]":[162],"95%CI":[163,196],",":[164,197],"p":[165,198],"0.001)":[167],"versus":[168],"Moreover,":[170],"relative":[171,190],"baseline,":[173],"greater":[176],"achieved":[180,221],"months,":[189],"rate":[191,249],"(RR)":[192],"1.30":[193],"[1.15,":[194],"1.45]":[195],"0.001.":[200],"Results":[201],"similar":[203],"for":[204],"\u2264":[207],"years":[209],"years;":[214],"66%":[215],"64%":[217],"patients,":[219],"respectively,":[220],"months.":[230],"reduction":[246],"during":[250],"follow-up":[254],"those":[261],"years.":[265]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-02-15T00:00:00"}